Stewart Morag H, Albert Mareike, Sroczynska Patrycja, Cruickshank V Adam, Guo Yanping, Rossi Derrick J, Helin Kristian, Enver Tariq
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA; Department of Stem Cell and Regenerative Medicine, Harvard University, Cambridge, MA;
Biotech Research and Innovation Center, Center for Epigenetics, and The Danish Stem Cell Center, University of Copenhagen, Copenhagen, Denmark; and.
Blood. 2015 Mar 26;125(13):2075-8. doi: 10.1182/blood-2014-08-596734. Epub 2015 Feb 5.
Jarid1b/KDM5b is a histone demethylase that regulates self-renewal and differentiation in stem cells and cancer; however, its function in hematopoiesis is unclear. Here, we find that Jarid1b is highly expressed in primitive hematopoietic compartments and is overexpressed in acute myeloid leukemias. Constitutive genetic deletion of Jarid1b did not impact steady-state hematopoiesis. In contrast, acute deletion of Jarid1b from bone marrow increased peripheral blood T cells and, following secondary transplantation, resulted in loss of bone marrow reconstitution. Our results reveal that deletion of Jarid1b compromises hematopoietic stem cell (HSC) self-renewal capacity and suggest that Jarid1b is a positive regulator of HSC potential.
Jarid1b/KDM5b是一种组蛋白去甲基化酶,可调节干细胞和癌症中的自我更新与分化;然而,其在造血过程中的功能尚不清楚。在此,我们发现Jarid1b在原始造血区室中高度表达,且在急性髓系白血病中过表达。Jarid1b的组成性基因缺失不影响稳态造血。相反,从骨髓中急性缺失Jarid1b会增加外周血T细胞数量,并且在二次移植后,会导致骨髓重建能力丧失。我们的结果表明,Jarid1b的缺失会损害造血干细胞(HSC)的自我更新能力,并提示Jarid1b是HSC潜能的正向调节因子。